In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Frovatriptan Drug Master File in Korea (Frovatriptan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Frovatriptan. The MFDS reviews the Frovatriptan KDMF as part of the drug registration process and uses the information provided in the Frovatriptan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Frovatriptan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Frovatriptan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Frovatriptan suppliers with KDMF on PharmaCompass.